(Circulation. 1997;96:44-49.)
© 1997 American Heart Association, Inc.
Articles |
Intermittent Claudication
A Risk Profile From The Framingham Heart Study
From the Framingham Heart Study (J.M.M., R.B.D., H.S., P.W.F.W.) Framingham, Mass; Section of Preventive Medicine and Epidemiology (J.M.M.) and Section of General Internal Medicine (J.M.M.) of Boston University School of Medicine, Boston, Mass; Division of Epidemiology and Clinical Applications of the National Heart, Lung, and Blood Institute (P.W.F.W.), Bethesda, Md; and the Department of Mathematics of Boston University (R.B.D., H.S.), Boston, Mass.
Correspondence to Dr Joanne Murabito, Framingham Heart Study, 5 Thurber St, Framingham, MA 01701. E-mail joanne{at}fram.nhlbi.nih.gov
Background Intermittent claudication identifies persons at increased risk for death and disability.
Methods and Results Using 38-year follow-up data for the original cohort in the Framingham Heart Study, we developed an intermittent claudication risk profile. Intermittent claudication occurred in a total of 381 men and women. Age, sex, serum cholesterol, hypertension, cigarette smoking, diabetes, and coronary heart disease were associated with an increased risk for claudication and were included in the profile. A pooled logistic regression model was used to compute the probability of intermittent claudication for specified levels of risk factors.
Conclusions The intermittent claudication risk profile allows physicians to identify high-risk individuals during a routine office visit and can be used to educate patients about modifiable risk factors, particularly smoking and blood pressure. Improved compliance with risk factor modification strategies may result in a beneficial impact on survival.
Key Words: claudication • hypertension • risk factors • smoking
This article has been cited by other articles:
 |
|
 |
|
  T. Dinh, S. Scovell, and A. Veves Review: Peripheral Arterial Disease and Diabetes: A Clinical Update International Journal of Lower Extremity Wounds, June 1, 2009; 8(2): 75 - 81. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Ketenci, A. K. Tuygun, A. Gorur, M. Bicer, B. Ozay, R. Gunay, M. R. Guney, M. Sargin, S. Cimen, M. M. Demirtas, et al. An approach to cultural adaptation and validation: the Intermittent Claudication Questionnaire Vascular Medicine, May 1, 2009; 14(2): 117 - 122. [Abstract] [PDF]
|
|
|
|
 |
|
 K.J. Dickinson, A.J. Cockbain, W. MacDonald, M. Shah, and S. Homer-Vanniasinkam The Physiological Effects of Short-term Smoking Cessation in Claudicants Angiology, April 1, 2009; 60(2): 159 - 163. [Abstract] [PDF]
|
|
|
|
 |
|
 M. E. O'Donnell, S. A. Badger, M. A. Sharif, R. R. Makar, I. S. Young, B. Lee, and C.V. Soong The Vascular and Biochemical Effects of Cilostazol in Diabetic Patients With Peripheral Arterial Disease Vascular and Endovascular Surgery, April 1, 2009; 43(2): 132 - 143. [Abstract] [PDF]
|
|
|
|
 |
|
 P.C. Bennett, S. Silverman, P.S. Gill, and G.Y.H. Lip Ethnicity and peripheral artery disease QJM, January 1, 2009; 102(1): 3 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W.F. Wilson Progressing From Risk Factors to Omics Circ Cardiovasc Genet, December 1, 2008; 1(2): 141 - 146. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ogawa, M. Nakayama, T. Morimoto, S. Uemura, M. Kanauchi, N. Doi, H. Jinnouchi, S. Sugiyama, Y. Saito, and for the Japanese Primary Prevention of Atheroscler Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial JAMA, November 12, 2008; 300(18): 2134 - 2141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W.F. Wilson, M. Pencina, P. Jacques, J. Selhub, R. D'Agostino Sr, and C. J. O'Donnell C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gaede, W. J. Valentine, A. J. Palmer, D. M.D. Tucker, M. Lammert, H.-H. Parving, and O. Pedersen Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes: Results and projections from the Steno-2 study Diabetes Care, August 1, 2008; 31(8): 1510 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Kalka and I. Baumgartner Gene and stem cell therapy in peripheral arterial occlusive disease Vascular Medicine, May 1, 2008; 13(2): 157 - 172. [Abstract] [PDF]
|
|
|
|
|
|
L. R. Qadan, A. A. Ahmed, H. A. Safar, M. A. Al-Bader, and A. A. Ali Prevalence of Metabolic Syndrome in Patients With Clinically Advanced Peripheral Vascular Disease Angiology, May 1, 2008; 59(2): 198 - 202. [Abstract] [PDF]
|
|
|
|
 |
|
 P. S. Douglas, B. Khandheria, R. F. Stainback, N. J. Weissman, E. D. Peterson, R. C. Hendel, R. F. Stainback, M. Blaivas, R. D. Des Prez, L. D. Gillam, et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 Appropriateness Criteria for Stress Echocardiography: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1127 - 1147. [Full Text] [PDF]
|
|
|
|
 |
|
 STRESS ECHOCARDIOGRAPHY WRITING GROUP, P. S. Douglas, B. Khandheria, R. F. Stainback, N. J. Weissman, TECHNICAL PANEL MEMBERS, E. D. Peterson, R. C. Hendel, R. F. Stainback, M. Blaivas, et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 Appropriateness Criteria for Stress Echocardiography: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: Endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine Circulation, March 18, 2008; 117(11): 1478 - 1497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. D'Agostino Sr, R. S. Vasan, M. J. Pencina, P. A. Wolf, M. Cobain, J. M. Massaro, and W. B. Kannel General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study Circulation, February 12, 2008; 117(6): 743 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Pradhan, S. Shrivastava, N. R. Cook, N. Rifai, M. A. Creager, and P. M Ridker Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk Circulation, February 12, 2008; 117(6): 823 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. H. Feringa, J. J. Bax, S. Hoeks, V. H. van Waning, A. Elhendy, S. Karagiannis, R. Vidakovic, O. Schouten, E. Boersma, and D. Poldermans A Prognostic Risk Index for Long-term Mortality in Patients With Peripheral Arterial Disease Arch Intern Med, December 10, 2007; 167(22): 2482 - 2489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto Metabolic Syndrome and Incident End-Stage Peripheral Vascular Disease: A 14-year follow-up study in elderly Finns Diabetes Care, December 1, 2007; 30(12): 3099 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sritara, C. Sritara, M. Woodward, S. Wangsuphachart, F. Barzi, B. Hengprasith, and T. Yipintsoi Prevalence and Risk Factors of Peripheral Arterial Disease in a Selected Thai Population Angiology, November 1, 2007; 58(5): 572 - 578. [Abstract] [PDF]
|
|
|
|
|
|
P. Poredos and B. Jug The Prevalence of Peripheral Arterial Disease in High Risk Subjects and Coronary or Cerebrovascular Patients Angiology, July 1, 2007; 58(3): 309 - 315. [Abstract] [PDF]
|
|
|
|
|
|
I. J. Kullo and A. R. Malik Arterial Ultrasonography and Tonometry as Adjuncts to Cardiovascular Risk Stratification J. Am. Coll. Cardiol., April 3, 2007; 49(13): 1413 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L.W. Bendermacher, J. A.W. Teijink, E. M. Willigendael, M.-L. Bartelink, R. J.G. Peters, R. A. de Bie, H. R. Buller, J. Boiten, M. Langenberg, and M. H. Prins A clinical prediction model for the presence of peripheral arterial disease -- the benefit of screening individuals before initiation of measurement of the ankle--brachial index: an observational study Vascular Medicine, February 1, 2007; 12(1): 5 - 11. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Cassar Intermittent claudication BMJ, November 11, 2006; 333(7576): 1002 - 1005. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Diehm and C. Diehm Subclinical atherosclerosis of lower limb arteries: a strong predictor for cardiovascular mortality Eur. Heart J., November 1, 2006; 27(21): 2495 - 2496. [Full Text] [PDF]
|
|
|
|
|
|
V. Schiano, G. Brevetti, G. Sirico, A. Silvestro, G. Giugliano, and M. Chiariello Functional status measured by walking impairment questionnaire and cardiovascular risk prediction in peripheral arterial disease: results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study Vascular Medicine, August 1, 2006; 11(3): 147 - 154. [Abstract] [PDF]
|
|
|
|
 |
|
 U. Laaser and J. Breckenkamp Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol Eur J Public Health, April 1, 2006; 16(2): 217 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Hirsch, Z. J. Haskal, N. R. Hertzer, C. W. Bakal, M. A. Creager, J. L. Halperin, L. F. Hiratzka, W. R.C. Murphy, J. W. Olin, J. B. Puschett, et al. ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1239 - 1312. [Full Text] [PDF]
|
|
|
|
|
|
N. A. Khan, S. A. Rahim, S. S. Anand, D. L. Simel, and A. Panju Does the Clinical Examination Predict Lower Extremity Peripheral Arterial Disease? JAMA, February 1, 2006; 295(5): 536 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al. Managing Abnormal Blood Lipids: A Collaborative Approach Circulation, November 15, 2005; 112(20): 3184 - 3209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Murabito, J. C. Evans, R. B. D'Agostino Sr., P. W. F. Wilson, and W. B. Kannel Temporal Trends in the Incidence of Intermittent Claudication from 1950 to 1999 Am. J. Epidemiol., September 1, 2005; 162(5): 430 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Youssef, P. Gupta, D. P. Mikhailidis, and G. Hamilton Risk Modification in Patients with Peripheral Arterial Disease: A Retrospective Survey Angiology, May 1, 2005; 56(3): 279 - 287. [Abstract] [PDF]
|
|
|
|
 |
|
 American Diabetes Association Peripheral Arterial Disease in People with Diabetes J Am Podiatr Med Assoc, May 1, 2005; 95(3): 309 - 319. [Full Text] [PDF]
|
|
|
|
|
|
L. Campeau, J. Lesperance, L. Bilodeau, A. Fortier, M.-C. Guertin, and G. L. Knatterud Effect of Cholesterol Lowering and Cardiovascular Risk Factors on the Progression of Aortoiliac Arteriosclerosis: A Quantitative Cineangiography Study Angiology, March 1, 2005; 56(2): 191 - 199. [Abstract] [PDF]
|
|
|
|
 |
|
 I. J. Kullo and C. M. Ballantyne Conditional Risk Factors for Atherosclerosis Mayo Clin. Proc., February 1, 2005; 80(2): 219 - 230. [Abstract] [PDF]
|
|
|
|
|
|
C. L. Leibson, J. E. Ransom, W. Olson, B. R. Zimmerman, W. M. O'Fallon, and P. J. Palumbo Peripheral Arterial Disease, Diabetes, and Mortality Diabetes Care, December 1, 2004; 27(12): 2843 - 2849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 American Diabetes Association Peripheral Arterial Disease in People With Diabetes Clin. Diabetes, October 1, 2004; 22(4): 181 - 189. [Full Text] [PDF]
|
|
|
|
|
|
R. C. Pasternak, M. H. Criqui, E. J. Benjamin, F. G. R. Fowkes, E. M. Isselbacher, P. A. McCullough, P. A. Wolf, and Z.-J. Zheng Atherosclerotic Vascular Disease Conference: Writing Group I: Epidemiology Circulation, June 1, 2004; 109(21): 2605 - 2612. [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, R. V. Milani, D. K. Arnett, J. R. Crouse III, M. M. McDermott, P. M Ridker, R. S. Rosenson, K. A. Taubert, and P. W.F. Wilson Atherosclerotic Vascular Disease Conference: Writing Group II: Risk Factors Circulation, June 1, 2004; 109(21): 2613 - 2616. [Full Text] [PDF]
|
|
|
|
|
|
D. P. Faxon, V. Fuster, P. Libby, J. A. Beckman, W. R. Hiatt, R. W. Thompson, J. N. Topper, B. H. Annex, J. H. Rundback, R. P. Fabunmi, et al. Atherosclerotic Vascular Disease Conference: Writing Group III: Pathophysiology Circulation, June 1, 2004; 109(21): 2617 - 2625. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. O'Hare, E. Vittinghoff, J. Hsia, and M. G. Shlipak Renal Insufficiency and the Risk of Lower Extremity Peripheral Arterial Disease: Results from the Heart and Estrogen/Progestin Replacement Study (HERS) J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1046 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Benchimol, V. Bernard, X. Pillois, N. T. Hong, D. Benchimol, and J. Bonnet Validation of a New Method of Detecting Peripheral Artery Disease by Determination of Ankle-Brachial Index Using an Automatic Blood Pressure Device Angiology, March 1, 2004; 55(2): 127 - 134. [Abstract] [PDF]
|
|
|
|
|
|
Peripheral Arterial Disease in People With Diabetes Diabetes Care, December 1, 2003; 26(12): 3333 - 3341. [Full Text] [PDF]
|
|
|
|
|
|
R. S Dieter, J. Tomasson, T. Gudjonsson, R. L Brown, M. Vitcenda, J. Einerson, and P. E McBride Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease Vascular Medicine, November 1, 2003; 8(4): 233 - 236. [Abstract] [PDF]
|
|
|
|
|
|
I. J Kullo, K. R Bailey, S. L. Kardia, T. H Mosley Jr, E. Boerwinkle, and S. T Turner Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study Vascular Medicine, November 1, 2003; 8(4): 237 - 242. [Abstract] [PDF]
|
|
|
|
|
|
J. J. F. Belch, E. J. Topol, G. Agnelli, M. Bertrand, R. M. Califf, D. L. Clement, M. A. Creager, J. D. Easton, J. R. Gavin III, P. Greenland, et al. Critical Issues in Peripheral Arterial Disease Detection and Management: A Call to Action Arch Intern Med, April 28, 2003; 163(8): 884 - 892. [Full Text] [PDF]
|
|
|
|
|
|
A. T Hirsch and A. M Gotto Jr Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction Vascular Medicine, November 1, 2002; 7(4): 323 - 331. [Abstract] [PDF]
|
|
|
|
|
|
A. I. Adler, R. J. Stevens, A. Neil, I. M. Stratton, A. J. M. Boulton, and R. R. Holman UKPDS 59: Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes Diabetes Care, May 1, 2002; 25(5): 894 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Vickrey, T. S. Rector, S. L. Wickstrom, P. M. Guzy, E. M. Sloss, P. B. Gorelick, S. Garber, D. F. McCaffrey, M. D. Dake, and R. A. Levin Occurrence of Secondary Ischemic Events Among Persons With Atherosclerotic Vascular Disease Stroke, April 1, 2002; 33(4): 901 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Hiatt Risk factor modification in intermittent claudication: effect on life expectancy and walking capacity Eur. Heart J. Suppl., March 1, 2002; 4(suppl_B): B50 - B54. [Abstract] [PDF]
|
|
|
|
|
|
N. C. Dolan, K. Liu, M. H. Criqui, P. Greenland, J. M. Guralnik, C. Chan, J. R. Schneider, A. L. Mandapat, G. Martin, and M. M. McDermott Peripheral Artery Disease, Diabetes, and Reduced Lower Extremity Functioning Diabetes Care, January 1, 2002; 25(1): 113 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. I Katzel, J. D Sorkin, C. C Powell, and A. W Gardner Comorbidities and exercise capacity in older patients with intermittent claudication Vascular Medicine, August 1, 2001; 6(3): 157 - 162. [Abstract] [PDF]
|
|
|
|
|
|
L. P. Asgeirsdottir, U. Agnarsson, and G. S. Jonsson Lower Extremity Blood Flow in Healthy Men: Effect of Smoking, Cholesterol, and Physical Activity -- A Doppler Study Angiology, July 1, 2001; 52(7): 437 - 445. [Abstract] [PDF]
|
|
|
|
|
|
E. Cosson, F. Paycha, P. Tellier, R. N. Sachs, A. Ramadan, J. Paries, J.-R. Attali, and P. Valensi Lower-Limb Vascularization in Diabetic Patients: Assessment by thallium-201 scanning coupled with exercise myocardial scintigraphy Diabetes Care, May 1, 2001; 24(5): 870 - 874. [Abstract] [Full Text]
|
|
|
|
|
|
A. T Hirsch, W. R Hiatt, and PARTNERS Steering Committee PAD awareness, risk, and treatment: new resources for survival - the USA PARTNERS program Vascular Medicine, February 1, 2001; 6(1_suppl): 9 - 12. [Abstract] [PDF]
|
|
|
|
|
|
L. Djousse, D. Levy, J. M. Murabito, L. A. Cupples, and R. C. Ellison Alcohol Consumption and Risk of Intermittent Claudication in the Framingham Heart Study Circulation, December 19, 2000; 102(25): 3092 - 3097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. Lazarous, E. F. Unger, S. E. Epstein, A. Stine, J. L. Arevalo, E. Y. Chew, and A. A. Quyyumi Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1239 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease Circulation, February 10, 1998; 97(5): 425 - 428. [Abstract] [Full Text] [PDF]
|
|